TAG ARCHIVE

POSTS TAGGED AS CRISPR-Cas9

“Bridged Nucleic Acid” as a Guide for Gene Editing

June 19, 2018 | | Posted in Newsletter

B-DNA
A synthetic guide molecule appears to increase the targeting accuracy in CRISPR-Cas9 gene editing, according to a research group at [MORE]

NIH Bets $190m on CRISPR

March 20, 2018 | | Posted in Newsletter

CRISPR DNA Repair
It appears that CRISPR gene editing has reached a tipping point. Clinical trials with this technology have already [MORE]

Gene Editing without Cutting DNA

February 13, 2018 | | Posted in Newsletter

Gene Editing
Salk Institute scientists have demonstrated how it’s possible to use two genetically engineered AAV vectors that result is altering [MORE]

Non-Viral Vectors for CRISPR Delivery

January 2, 2018 | | Posted in Newsletter

MIT CRISPR Gene Editing Tool Without Viruses
CRISPR-Cas9 gene editing has mostly depended on viral vectors to deliver the cutting enzyme [MORE]

CRISPR-Cpf1 Gene Editing

August 22, 2017 | | Posted in Newsletter

CRISPR Cas Method
Gene editing technology known as CRISPR has only been known to science for four years, but its impact [MORE]

Using Stem Cells to Grow Inner Ear Organs

July 18, 2017 | | Posted in Newsletter

Human Inner Ear Organoid
Stem cell-derived tissue from any organ offers a way to test therapeutic drugs. In this piece, Indiana [MORE]

CRISPR Gene Editing by Middle Schoolers

July 18, 2017 | | Posted in Newsletter

Genspace Student Programs
Max Planck once observed that major breakthroughs in science rarely proceed by converting skeptics. Instead, breakthroughs are taught [MORE]

CRISPR Diagnostics for Infectious Diseases

June 13, 2017 | | Posted in Newsletter

MIT Professors Collins and Zhang SHERLOCK Developers
CRISPR-Cas9 gene editing has been thought to be most useful in altering DNA, rather [MORE]

Nanoparticle-Enabled Gene Editing

April 18, 2017 | | Posted in Newsletter

CRISPR Delivery Mechanism
Getting CRISPR-Cas 9 molecules to their target cells without damage or off-targeting has been an obstacle for gene [MORE]

First Use of CRISPR/Cas 9 in a Human Clinical Trial

January 10, 2017 | | Posted in Newsletter

Gene Editing CRISPR-Cas9
Last October, clinical trial operators at the West China Hospital in Chengdu (Sichuan Province) altered immune cells from [MORE]

Nanoparticles Delivery Synthetic DNA in Treating Thalassemia in Lab Animals

December 6, 2016 | | Posted in Newsletter

Thalassemia
Several years ago a gene repair technique called “chimeraplasty” looked promising, though it never reached fruition. The idea was to [MORE]

A Path to Precision Cardiac Medicine

October 25, 2016 | | Posted in Newsletter

CRISPR-Cas9 Mode of Action
About 30% of drugs in clinical trials are withdrawn because of safety issues, several of which present [MORE]

Gene Editing’s Newcomers

October 25, 2016 | | Posted in Newsletter

MiRNA Mechanisms
CRISPR-Cas9 gene editing has created enormous scientific interest and it may soon antiquate itself as researchers around the world [MORE]

CRISPR meets the Digenome

March 29, 2016 | | Posted in Newsletter

Multiplex Digenome Seq
Thinking about the prospects of CASPR-Cas9 gene editing might bring to mind the title of Irving Stone’s biography [MORE]